Health

Progressive supranuclear palsy (PSP) is a neurodegenerative disorder that affects motor function and cognition. A recent post hoc analysis conducted by Anne-Marie Wills, MD, MPH, and her colleagues at Massachusetts General Hospital in Boston, has shed light on the potential impact of benzodiazepine derivatives on the progression of PSP. The study revealed that individuals with
0 Comments
A phase II study has demonstrated that hepatic arterial infusion pump (HAIP) chemotherapy with floxuridine offers significant improvements in overall survival (OS) for patients with advanced intrahepatic cholangiocarcinoma (iCCA). Bas Groot Koerkamp, MD, PhD, of the Erasmus MC Cancer Institute in Rotterdam, the Netherlands, reported that patients treated with HAIP chemotherapy combined with systemic chemotherapy
0 Comments
Long COVID, a condition that affects individuals long after their initial COVID-19 infection, has posed numerous challenges in terms of understanding its underlying mechanisms and developing effective treatments. Recent research conducted by Onur Boyman, MD, and his colleagues at the University of Zurich in Switzerland has shed new light on the role of blood proteins
0 Comments
The use of gabapentinoids, such as gabapentin, in patients with chronic obstructive pulmonary disease (COPD) has been found to be associated with an increased risk for severe exacerbations, according to a population-based cohort study conducted in Canada. The study, led by Christel Renoux, MD, PhD, examined over 27,000 COPD patients and found that those who
0 Comments
Access to affordable medications is a major concern for many patients in the United States. Rising healthcare costs and high copayments often leave individuals struggling to afford their medical care. This issue is particularly significant for those with chronic conditions like diabetes and high blood pressure, who rely on regular medication to manage their conditions
0 Comments
Childhood trauma has long been associated with a range of negative outcomes in adulthood, including mental health disorders and addictive behaviors. A recent cross-sectional study published in JAMA Network Open suggests that childhood trauma-related emotion dysregulation may partly explain why some long-term smokers struggle to quit nicotine. The study focused specifically on the temporal dynamics
0 Comments
A phase III trial has demonstrated that the addition of oral clarithromycin to beta-lactam antibiotic treatment effectively improves the clinical response of individuals with community-acquired pneumonia (CAP) and systemic inflammatory response syndrome (SIRS). According to the study published in Lancet Respiratory Medicine, patients who received clarithromycin in addition to standard care had a significantly higher
0 Comments